Skip to content

Expiring federal contract

75N93024P01131 — United Biopharma, INC.

Department of Health and Human Services · National Institutes of Health

Contract / PIID
75N93024P01131
Incumbent
United Biopharma, INC.
Incumbent UEI
KWMNCKBPM4K6
Current end date
December 31, 2026
Potential total value
$400,000
Obligated
$400,000
NAICS
325412 — Pharmaceutical Preparation Manufacturing
PSC
6505 — DRUGS AND BIOLOGICALS
Set-aside
Not stated
Start date
September 30, 2024
Place of performance
Not stated
Award type
PURCHASE ORDER

Source: USASpending.gov award record, last checked November 19, 2026. Place of performance as reported by USASpending.

What the contract covers

CLINICAL GRADE MONOCLONAL ANTIBODY UB-421 INCLUDES: ONE 100-LITER BATCH OF GMP-MANUFACTURER UB-421, STERILE VIALING, AND LONG-TERM AND ACCELERATED STABILITY STUDIES.

Likely rebid window (estimate)

  • Sources Sought / RFI: about Dec 2025 – Jun 2026 (6–12 months before the end date)
  • RFP: about Aug 2026 – Oct 2026 (2–4 months before the end date)

In the final months before the current end date.

Estimated from the current end date using typical federal recompete timing. Agencies set their own schedules, and contracts are often extended. This is not a published solicitation date.

Track this recompete free

  • Change history: no changes recorded since Mindy began tracking this contract.
  • Alerts: get an email when the end date moves or the follow-on is posted.
  • Contacts: the buying office and small-business contacts for this agency.

Other contracts expiring at Department of Health and Human Services (NAICS 325412)